The cytosol activity of thymidine phosphorylase in endometrial cancer

Journal of Experimental and Clinical Cancer Research

Volumn 27, Issue 1, 2008, Pages

  Miszczak Zaborska, Elzbieta ^a   Kubiak, Robert ^a   Bieńkiewicz, Andrzej ^a   Bartkowiak, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; THYMIDINE PHOSPHORYLASE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOL; ENDOMETRIUM CANCER; ENZYME ACTIVITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; ENDOMETRIUM TUMOR; ENZYMOLOGY; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; CYTOSOL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICROVESSELS; MIDDLE AGED; THYMIDINE PHOSPHORYLASE;

EID: 57049089440     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-27-64     Document Type: Article

References (50)

1. Kinetic studies of thymidine phosphorylase from mouse liver. MH Iltzsch MH elKouni S Cha, Biochemistry 1985 24 6799 6807 10.1021/bi00345a011 4074727
2. Human platelet-derived endothelial cell growth factor is homologous to Escherichia coli thymidine phosphorylase. GJ Barton CP Ponting G Spraggon C Finnis D Sleep, Protein Science 1992 1 688 690 1304367
3. Thymidine phosphorylase activity associated with platelet-derived endothelial cell growth factor. T Sumizawa T Furukawa M Haraguchi A Yoshimura A Takeyasu M Ishizawa Y Yamada S Akiyama, J Biochem 1993 114 9 14 8407883
4. Expression of platelet-derived endothelial cell growth factor in Escherichia coli and confirmation of its thymidine phosphorylase activity. A Moghaddam R Bicknell, Biochemistry 1992 31 12141 12146 10.1021/bi00163a024 1457409
5. Structural properties of 3.0 kb and 3.2 kb transcripts encoding platelet-derived endothelial cell growth factor/thymidine phosphorylase in A431 cells. K Usuki LJ Gonez C Wernstedt A Morén K Miyazono L Claesson-Welsh CH Heldin, Biochim Biophys Acta 1994 1222 411 414 10.1016/0167-4889(94)90049-3 8038210
6. Angiogenic activity of enzyme. M Haraguchi K Miyadera K Uemura T Sumizawa T Furukawa K Yamada S Akiyama Y Yamada, Nature 1994 368 198 10.1038/368198a0 7511797
7. Purification and tissue distribution of human thymidine phosphorylase; high expression in lymphocytes, reticulocytes and tumors. A Yoshimura Y Kuwazuru T Furukawa H Yoshida K Yamada S Akiyama, Biochim Biophys Acta 1990 1034 107 113 2328255
8. The activity and expression of thymidine phosphorylase in human solid tumours. Y Takebayashi K Yamada K Miyadera T Sumizawa T Furukawa F Kinoshita D Aoki H Okumura Y Yamada S Akiyama T Aikou, Eur J Cancer 1996 32 1227 32 10.1016/0959-8049(96)00061-5
9. The activity of thymidine phosphorylase in the uterine myomas and the myometrium in perimenopausal women. E Miszczak-Zaborska J Greger K Wozniak U Kowalska-Koprek T Pajszczyk-Kieszkiewicz, Z Naturforsch [C] 1997 52 850 854 9463943
10. Correlation between expression of platelet-derived endothelial cell growth factor (thymidine phosphorylase) and microvessel density in early-stage human colon carcinomas. T Saeki M Tanada S Takashima H Saeki W Takiyama N Nishimoto S Moriwaki, Jpn J Clin Oncol 1997 27 227 30 10.1093/jjco/27.4.227 9379508
11. Thymidine phosphorylase/platelet-derived endothelial cell growth factor expression associated with hepatic metastasis in gastric carcinoma. K Maeda YS Chung Y Ogawa S Takatsuka SM Kang M Ogawa T Sawada N Onoda Y Kato M Sowa, Br J Cancer 1996 73 884 888 8611421
12. Platelet-derived endothelial cell growth factor predicts of progression and recurrence in primary epithelial ovarian cancer. Y Watanabe H Nakai H Ueda K Nozaki H Hoshiai K Noda, Cancer Lett 2003 200 173 176 10.1016/S0304-3835(03) 00413-0 14568172
13. Thymidine phosphorylase mediates the sensitivity of human colon carcinoma cells to 5-fluorouracil. EL Schwartz N Baptiste S Wadler Makower, J Biol Chem 1995 270 32 19073 19077 10.1074/jbc.270.32.19073 7642571
14. on behalf of the 5'-BC Study Group: Prognostic and predictive value of thymidine phosphorylase activity in early-stage breast cancer patients. T Tominaga M Toi Y Ohashi O Abe, Clin Breast Cancer 2002 3 55 64 10.3816/CBC.2002.n.012 12020396
15. Expression of thymidine phosphorylase as an effect prediction factor for uterine cervical squamous cell carcinoma after radiotherapy: an immunohistochemical study. M Nakashima T Nakano Y Ametani H Funamoto A Uchiyama A Miwa S Miyata M Shoji T Kondo S Satake Y Kojima, Int J Gynecol Cancer 2006 16 1309 1313 10.1111/j.1525-1438.2006.00455.x 16803522
16. The activity of thymidine phosphorylase correlates with tumor size and lymph nodes status in breast carcinoma. R Kubiak E Miszczak-Zaborska D Jesionek-Kupnicka J Greger, Z Naturforsch [C] 1999 54 1096 1102 10685502
17. The activity of thymidine phosphorylase as a new ovarian tumor marker. E Miszczak-Zaborska K Wojcik-Krowiranda R Kubiak A Bienkiewicz J Bartkowiak, Gynecol Oncol 2004 94 86 92 10.1016/j.ygyno.2004.04.011 15262124
18. Platelet-derived endothelial cell growth factor predicts of progression and recurrence in primary epithelial ovarian cancer. Y Watanabe H Nakai H Ueda K Nozaki H Hoshiai K Noda, Cancer Lett 2003 2000 173 176 10.1016/S0304-3835(03) 00413-0
19. Sex steroid-dependent angiogenesis in uterine endometrial cancers. J Fujimoto H Toyoki I Jahan SM Alam H Sakaguchi E Sato T Tamaya, J Steroid Biochem Mol Biol 2005 93 161 165 10.1016/j.jsbmb.2004.12.021 15860258
20. Thymidine phosphorylase expression in tumor-infiltrating macrophages may be correlated with poor prognosis in uterine endometrial cancer. Y Tanaka H Kobayashi M Suzuki N Kanayama M Suzuki T Terao, Hum Pathol 2002 33 1105 1113 10.1053/hupa.2002.129203 12454815
21. Thymidine phosphorylase expression in endometrial carcinomas. E Sivridis A Giatromanolaki MI Koukourakis R Bicknell AL Harris KC Gatter, Clin Exp Metastasis 1999 17 445 450 10.1023/A:1006603709248 10651312
22. Corpus cancer staging. FIGO news, Int J Gynaecol Obstet 1989 28 190 2563709
23. Histological typing of female genital tract tumors. H Poulsen CW Teylor LH Sobin, International histologic classification of tumors Geneva: World Health Organization 1975 13 63 73
24. Current pathologic methods for measuring intratumoral microvessel density within breast carcinoma and other solid tumors. N Weidner, Breast Cancer Res Treat 1995 36 169 180 10.1007/BF00666038 8534865
25. Platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in normal tissues: an immunohistochemical study. SB Fox A Moghaddam M Westwood H Turley R Bicknell KC Gatter AL Harris, J Pathol 1995 176 183 190 10.1002/path.1711760212 7636628
26. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein - dye binding. MA Bradford, Anal Biochem 1976 72 248 254 10.1016/0003-2697(76)90527-3 942051
27. Pyrimidine nucleoside phosphorylase activity in normal tissues of the uterus and ovary and in benign and malignant lesions of these organs. M Suzuki N Usui Y Furugen N Mitsuhasi, Int J Clin Oncol 2001 6 19 24 10.1007/PL00012074 11706522
28. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. R Fujiwaki K Hata K Iida M Koike K Miyazaki, Gynecol Oncol 1998 68 247 252 10.1006/gyno.1997.4929 9570975
29. Thymidine phosphorylase expression is predominantly observed in stroma of well-differentiated adenocarcinoma of endometrium and correlates with a frequency of vascular involvement. H Sakamoto T Shirakawa S Izuka T Igarashi K Kinoshita K Ohtani T Takami Y Nakayama K Teramoto K Satoh, Gynecol Oncol 1999 7 298 305 10.1006/gyno.1998.5122
30. Thymidine phosphorylase expression in endometrial carcinomas. E Sivridis A Giatromanolaki MI Koukourakis R Bicknell AL Harris KC Gatter, Clin Exp Metasatasis 1999 17 445 450 10.1023/A:1006603709248
31. S Kamoi M Kawamoto Y Ohta H Takahashi T Araki, [Immunohistochemistry and activities of thymidine phosphorylase in the tissues of uterine cervical and endometrial carcinomas] Gan To Kagaku Ryoho 1996 23 801 804
32. Independent prognostic importance of microvessel density in endometrial carcinoma. HB Salvesen OE Iversen LA Akslen, Br J Cancer 1998 77 1140 1144 9569052
33. Tumor angiogenesis, hepatocyte growth factor, and c-Met expression in endometrial carcinoma. S Wagatsuma R Konno S Sato A Yajima, Cancer 1998 82 520 530 10.1002/(SICI)1097-0142(19980201)82:3<520::AID-CNCR14>3.0.CO;2-3 9452270
34. Angiogenesis in endometrial carcinoma. T Kaku T Kamura N Kinukawa H Kobayashi K Sakai N Tsuruchi T Saito S Kawauchi M Tsuneyoshi H Nakano, Cancer 1997 80 741 747 10.1002/(SICI)1097-0142(19970815)80:4<741::AID-CNCR13>3.0. CO;2-T 9264358
35. Tumour angiogenesis. SB Fox KC Gatter AL Harris, J Pathol 1996 179 232 237 10.1002/(SICI)1096-9896(199607)179:3<232::AID-PATH505>3.0.CO;2-A 8774475
36. Angiogenesis and platelet-derived endothelial cell growth factor/thymidine phosphorylase expression in endometrial cancer. N Seki J Kodama A Hongo Y Miyagi M Yoshinouchi T Kudo, Int J Oncol 1999 15 781 786 10493962
37. Angiogenesis in endometrial hyperplasia and stage I endometrial carcinoma. O Abulafia WE Triest DM Sherer CC Hansen F Ghezzi, Obstet Gynecol 1995 86 479 485 7545803
38. Immunohistochemical expression of thymidine phosphorylase in human endometrial cancer. R Fujiwaki K Hata K Iida M Koike K Miyazaki, Gynecol Oncol 1998 68 247 252 10.1006/gyno.1997.4929 9570975
39. Thymidine phosphorylase/platelet-derived endothelial cell growth factor (PD-ECGF) associated with prognosis in renal cell carcinoma. K Suzuki T Morita S Hashimoto A Tokue, Urol Res 2001 29 7 12 10.1007/s002400000154 11310220
40. Tumour and Angiogenesis Research Group. Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas. E Sivridis A Giatromanolaki P Anastasiadis L Georgiou KC Gatter AL Harris R Bicknell MI Koukourakis Tumour and Angiogenesis Research Group, J Pathol 2002 196 416 422 10.1002/path.1060 11920737
41. Evaluation of tumor angiogenesis and thymidine phosphorylase tissue expression in patients with endometrial cancer. A Mazurek P Kuc S Terlikowski T Laudanski, Neoplasma 2006 53 242 246 16652195
42. Angiogenesis in the endometrium. MC Rees R Bicknell, Angiogenesis 1998 2 29 35 10.1023/A:1009098225645 14517373
43. Angiogenesis. J Folkman Y Shing, J Biol Chem 1992 267 10931 4 1375931
44. Thymidine phosphorylase, 2-deoxy-D-ribose and angiogenesis. NS Brown R Bicknell, Biochem J 1998 334 1 338 9693094
45. Specific simple sugars promote chemotaxis and chemokinesis of corneal endothelial cells. T Vogel DA Blake DR Whikehart NH Guo VS Zabrenetzky DD Roberts, J Cell Physiol 1993 157 359 366 10.1002/jcp.1041570220 8227167
46. Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors. NS Brown A Jones C Fujiyama AL Harris R Bicknell, Cancer Res 2000 60 6298 6302 11103787
47. Nonenzymatic glycosylation, the Maillard reaction and the aging process. VM Monnier, J Gerontol 1990 45 B105 111 2195101
48. Thymidine phosphorylase: its role in sensitivity and resistance to anticancer drugs. SP Ackland GJ Peters, Drug Resist Updat 1999 2 205 10.1054/drup.1999.0089 11504493
49. Thymidine phosphorylase and fluoropyrimidines efficacy: a Jekyll and Hyde story. J Ciccolini A Evrard P Cuq, Curr Med Chem Anticancer Agents 2004 4 71 81 10.2174/1568011043482089 15032715
50. The role of platelet-derived endothelial cell growth factor/thymidine phosphorylase in tumor behavior. IV Bijnsdorp M de Bruin AC Laan M Fukushima GJ Peters, Nucleosides Nucleotides Nucleic Acids 2008 27 681 691 10.1080/15257770802143988 18600526